VIPS Business Company

VIPS Business SA is a Swiss biotechnology company focused on enhancing the safety of blood transfusions through advanced viral inactivation technologies. The company specializes in the Solvent-Detergent (S/D) treatment of plasma and cryoprecipitate, producing pathogen-reduced blood components that are critical for managing bleeding disorders like Hemophilia A and von Willebrand Disease. Its flagship products, VIPS S/D Plasma and VIPS S/D Cryoprecipitate, offer a high-quality, cost-effective solution for blood transfusion centers, particularly in emerging markets where access to industrial plasma derivatives is limited. By providing integrated kits and processing systems, VIPS Business SA enables local blood establishments to achieve international safety standards for blood products. The company is headquartered in Fribourg, Switzerland, and collaborates with global health organizations to improve the availability of safe plasma proteins worldwide.